首页> 美国卫生研究院文献>Toxicology Reports >Trifluoperazine inhibits acetaminophen-induced hepatotoxicity and hepatic reactive nitrogen formation in mice and in freshly isolated hepatocytes
【2h】

Trifluoperazine inhibits acetaminophen-induced hepatotoxicity and hepatic reactive nitrogen formation in mice and in freshly isolated hepatocytes

机译:三氟拉嗪抑制小鼠和新鲜分离的肝细胞中对乙酰氨基酚引起的肝毒性和肝反应性氮的形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abbreviations: APAP, Acetaminophen; NAPQI, N-Acetyl-p-benzoquinone imine; GSH, reduced glutathione; APAP-cys, 3-(cystein-S-yl)-acetaminophen; NO, Nitric Oxide; iNOS, Inducible nitric oxide synthase (NOS2); nNOS, Neuronal nitric oxide synthase (NOS1); GSNO, S-Nitrosoglutathione; GSSG, glutathione disulfide; NANT, N-[(4S)-4-amino-5-[(2-aminoethyl) amino] pentyl]-N’-nitroguanidinetris (trifluoroacetate); MPT, Mitochondrial Permeability Transition; LDH, Lactate Dehydrogenase; OCR, Oxygen Consumption Rate; 3-NT, 3-Nitrotyrosine; TFP, TrifluoperazineKeywords: Acetaminophen, Neuronal nitric oxide, Oxidative stress, Mitochondria

Abstract

The hepatotoxicity of acetaminophen (APAP) occurs by initial metabolism to N-acetyl-p-benzoquinone imine which depletes GSH and forms APAP-protein adducts. Subsequently, the reactive nitrogen species peroxynitrite is formed from nitric oxide (NO) and superoxide leading to 3-nitrotyrosine in proteins. Toxicity occurs with inhibited mitochondrial function. We previously reported that in hepatocytes the nNOS (NOS1) inhibitor NANT inhibited APAP toxicity, reactive nitrogen and oxygen species formation, and mitochondrial dysfunction. In this work we examined the effect of trifluoperazine (TFP), a calmodulin antagonist that inhibits calcium induced nNOS activation, on APAP hepatotoxicity and reactive nitrogen formation in murine hepatocytes and in vivo. In freshly isolated hepatocytes TFP inhibited APAP induced toxicity, reactive nitrogen formation (NO, GSNO, and 3-nitrotyrosine in protein), reactive oxygen formation (superoxide), loss of mitochondrial membrane potential, decreased ATP production, decreased oxygen consumption rate, and increased NADH accumulation. TFP did not alter APAP induced GSH depletion in the hepatocytes or the formation of APAP protein adducts which indicated that reactive metabolite formation was not inhibited. Since we previously reported that TFP inhibits the hepatotoxicity of APAP in mice without altering hepatic APAP-protein adduct formation, we examined the APAP treated mouse livers for evidence of reactive nitrogen formation. 3-Nitrotyrosine in hepatic proteins and GSNO were significantly increased in APAP treated mouse livers and decreased in the livers of mice treated with APAP plus TFP. These data are consistent with a hypothesis that APAP hepatotoxicity occurs with altered calcium metabolism, activation of nNOS leading to increased reactive nitrogen formation, and mitochondrial dysfunction.
机译:<!-fig ft0-> <!-fig @ position =“ anchor” mode =文章f4-> <!-fig mode =“ anchred” f5-> <!-fig / graphic | fig / alternatives / graphic mode =“ anchored” m1-> 缩写: APAP,对乙酰氨基酚; NAPQI,N-乙酰基-对-苯醌亚胺; GSH,还原型谷胱甘肽; APAP-cys,3-(半胱氨酸-S-基)-对乙酰氨基酚; NO,一氧化氮; iNOS,诱导型一氧化氮合酶(NOS2); nNOS,神经元一氧化氮合酶(NOS1); GSNO,S-亚硝基谷胱甘肽; GSSG,谷胱甘肽二硫化物; NANT,N-[((4S)-4-氨基-5-[(2-氨基乙基)氨基]戊基] -N’-硝基胍三(三氟乙酸酯); MPT,线粒体通透性转变; LDH,乳酸脱氢酶; OCR,耗氧率; 3-NT,3-硝基酪氨酸; TFP,三氟拉嗪关键字:对乙酰氨基酚,神经元一氧化氮,氧化应激,线粒体

摘要肝毒性对乙酰氨基酚(APAP)的产生是通过初始代谢为N-乙酰基-对-苯醌亚胺而产生的,该亚胺消耗GSH并形成APAP-蛋白质加合物。随后,反应性氮物种过氧亚硝酸盐由一氧化氮(NO)和超氧化物形成,导致蛋白质中的3-硝基酪氨酸。毒性发生与线粒体功能受阻。我们先前曾报道过,在肝细胞中,nNOS(NOS1)抑制剂NANT抑制APAP毒性,活性氮和氧物种形成以及线粒体功能障碍。在这项工作中,我们检查了三氟哌嗪(TFP),一种钙调蛋白拮抗剂,可抑制钙诱导的nNOS活化,对APAP肝毒性和鼠肝细胞及体内活性氮的形成有影响。在新鲜分离的肝细胞中,TFP抑制了APAP诱导的毒性,活性氮的形成(蛋白质中的NO,GSNO和3-硝基酪氨酸),活性氧的形成(超氧化物),线粒体膜电位的丧失,ATP产量的降低,耗氧率的降低和增加NADH积累。 TFP不会改变APAP诱导的肝细胞GSH耗竭或APAP蛋白加合物的形成,这表明反应性代谢物的形成未受到抑制。由于我们先前曾报道TFP抑制小鼠APAP的肝毒性而不改变肝脏APAP蛋白加合物的形成,因此我们检查了APAP处理过的小鼠肝脏中反应性氮形成的证据。 APAP治疗的小鼠肝脏中肝蛋白和GSNO中的3-硝基酪氨酸显着增加,而APAP加TFP治疗的小鼠肝脏中的3-硝基酪氨酸显着降低。这些数据与以下假设相一致:APAP的肝毒性发生在钙代谢改变,nNOS激活导致活性氮形成增加以及线粒体功能障碍时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号